Thanks Tada.  Reading through the messages on this forum, clearly BearDownAZ has provided a lot of the heavy weight biology/detailed research highlights...so I won't dwell on them, given my sorely inadequate understanding of the science of epigenetics.  What I find very reassuring is that there is not a single piece of data that suggests RVX208 won't work...except for the low # of 3 point MACE episodes in Phase 2.

People like me who look to charts for clues (clutching for straws?) are quite pleased to see the way the share price is trending slowly but surely higher.  We need to break decisively above $3.5 before we can breathe a sign of relief and say...yes, the market is more hopeful...or as you put it...the earth is slowly but surely moving.

Re the volumes traded...yes, they are really low.  That makes it even more "unknown" to the market...so if the news arrives as we hope...then the market could react violently higher for sure.  In 2015, not sure why the shares went from $0.5 to $3 in a matter of 3 months on volumes which were about 200,000 shares a day.  In other words, with good data, a move up of more than 5 times is easy to see.